Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ocular aldehyde dehydrogenase in rodents

F S Messiha

    Neurotoxicology
    |December 1, 1981
    PubMed
    Summary

    Researchers identified NAD-dependent ocular aldehyde dehydrogenase in rodents, noting its species and strain variability. Cyclobenzaprine administration induced this enzyme, unlike other tested substances.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Developmental toxicity of cesium in the mouse.

    General pharmacology·1994
    Same author

    Pharmacological aspects of gonadal alcohol and aldehyde-dehydrogenase.

    General pharmacology·1993
    Same author

    beta-Casomorphin-immunoreactivity in the brain stem of the human infant.

    Research communications in chemical pathology and pharmacology·1993
    Same author

    Fluoxetine: adverse effects and drug-drug interactions.

    Journal of toxicology. Clinical toxicology·1993
    Same author

    Classifying cytostatics on the basis of their angiocidal and angiostatic effects.

    Journal of medicine·1993
    Same author

    Fluoxetine: a spectrum of clinical applications and postulates of underlying mechanisms.

    Neuroscience and biobehavioral reviews·1993

    Area of Science:

    • Biochemistry
    • Pharmacology
    • Ophthalmology

    Background:

    • Aldehyde dehydrogenase (ALDH) enzymes are crucial for metabolizing aldehydes.
    • Ocular ALDH activity and its regulation are not well-characterized.
    • Rodent models are frequently used to study enzyme kinetics and drug interactions.

    Purpose of the Study:

    • To report the presence and characterize NAD-dependent ocular aldehyde dehydrogenase in rodents.
    • To investigate the species and strain dependency of ocular ALDH.
    • To examine the effects of specific compounds on ocular ALDH activity in vitro and in vivo.

    Main Methods:

    • Enzyme activity assays were performed on ocular and hepatic tissues from various rodent species and strains.
    • In vitro inhibition studies using d-amphetamine were conducted on rat eye ALDH.
    • In vivo studies involved administering cyclobenzaprine, CNS-stimulants, ethanol, and a monoamine oxidase inhibitor to rodents, followed by assessment of ocular ALDH levels.

    Main Results:

    • NAD-dependent ocular aldehyde dehydrogenase was identified in rodents, exhibiting significant species and strain-specific differences.
    • Ocular ALDH demonstrated considerably higher specific activity compared to hepatic ALDH across the studied species.
    • d-Amphetamine non-competitively inhibited rat ocular ALDH in vitro.
    • Short-term administration of cyclobenzaprine induced ocular ALDH, whereas CNS-stimulants, ethanol, and a monoamine oxidase inhibitor showed no effect on endogenous ALDH in vivo.

    Conclusions:

    • Rodent ocular ALDH is a distinct enzyme with unique kinetic properties and regulatory mechanisms.
    • Ocular ALDH activity is significantly influenced by genetic factors (species and strain) and pharmacological agents.
    • Cyclobenzaprine represents a potential modulator of ocular aldehyde dehydrogenase, warranting further investigation into its therapeutic implications.

    Related Experiment Videos